We describe a 60-year-old man who underwent elective aortic valve replacement and concurrent single graft coronary artery bypass surgery with acute intraoperative hypertension. The early suspicion of a pheochromocytoma and immediate aggressive pharmacologic intervention are discussed. Expeditious surgery contributed to the good outcome. It is possible that the short implant time of the sutureless valve may have been beneficial, but this is speculative. The management of an undiagnosed pheochromocytoma presenting during general anesthesia is reviewed.
From the *Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford, UK; †Department of Cardiothoracic Surgery, National Heart Centre, Singapore; and ‡Department of Cardiac Anesthesia, John Radcliffe Hospital, Oxford, UK.
Accepted for publication May 21, 2010.
Disclosure: Ravi Pillai, FRCS, is the principal investigator at Oxford, UK, of the 3f Enable valve for ATS Medical, Inc., Minneapolis, MN USA.
Address correspondence and reprint requests to Jia-Lin Soon, FRCS(CTh), Department of Cardiothoracic Surgery, Level 1, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU UK. E-mail: firstname.lastname@example.org.